Merck支付高达20亿美元的新减肥药丸 由中国的半田制药公司提供。 Merck pays up to $2 billion for a new weight loss pill from Chinese firm Hansoh Pharma.

Merck与中国药商Hansoh Pharma达成了一项协议, 实验性减肥药片HS-10535, 价值可能高达20亿美元。 Merck has struck a deal with Chinese drugmaker Hansoh Pharma for an experimental weight loss pill, HS-10535, which could be worth up to $2 billion. Merck将提前支付1.12亿美元,并有可能根据里程碑和销售额支付额外款项。 Merck will pay $112 million upfront, with potential additional payments based on milestones and sales. 该药物针对的是肠内荷尔蒙GLP-1,类似于现有的减肥药物。 The drug targets the gut hormone GLP-1, similar to existing weight loss medications. 这一收购是制药业向日益增长的肥胖药物市场推进的一部分。 This acquisition is part of the pharmaceutical industry's push into the growing obesity drug market.